| ?? |
?? ?? |
CAS |
MF |
 |
GSK 343 |
1346704-33-3 |
C31H39N7O2 |
 |
UNC 1999 |
1431612-23-5 |
C33H43N7O2 |
 |
1-Cyclopentyl-N-((4,6-diMethyl-2-oxo-1,2-dihydropyridin-3-yl)Methyl)-6-(4-(MorpholinoMethyl)phenyl)-1H-indazole-4-carboxaMide |
1396772-26-1 |
C32H37N5O3 |
 |
UNC 0631 |
1320288-19-4 |
C37H61N7O2 |
 |
Tazemetostat (EPZ-6438) |
1403254-99-8 |
C34H44N4O4 |
 |
ZOTAROLIMUS |
221877-54-9 |
C52H79N5O12 |
![N-[4-[1-(1,4-Dioxaspiro[4.5]dec-8-yl)-4-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]-N'-methylurea](/CAS2/GIF/1144068-46-1.gif) |
N-[4-[1-(1,4-Dioxaspiro[4.5]dec-8-yl)-4-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]-N'-methylurea |
1144068-46-1 |
C27H33N7O4 |
![N-Ethyl-N'-[4-[5,6,7,8-tetrahydro-4-[(3S)-3-methyl-4-morpholinyl]-7-(3-oxetanyl)pyrido[3,4-d]pyrimidin-2-yl]phenyl]urea](/CAS/GIF/1207360-89-1.gif) |
N-Ethyl-N'-[4-[5,6,7,8-tetrahydro-4-[(3S)-3-methyl-4-morpholinyl]-7-(3-oxetanyl)pyrido[3,4-d]pyrimidin-2-yl]phenyl]urea |
1207360-89-1 |
C24H32N6O3 |
![5-(4-aMino-1-isopropyl-1H-pyrazolo[3,4-d]pyriMidin-3-yl)benzo[d]oxazol-2-aMine](/CAS/GIF/1224844-38-5.gif) |
5-(4-aMino-1-isopropyl-1H-pyrazolo[3,4-d]pyriMidin-3-yl)benzo[d]oxazol-2-aMine |
1224844-38-5 |
C15H15N7O |
 |
WYE-354 |
1062169-56-5 |
C24H29N7O5 |
![9-(6-Amino-3-pyridinyl)-1-[3-(trifluoromethyl)phenyl]benzo[h]-1,6-naphthyridin-2(1H)-one](/CAS/GIF/1223001-51-1.gif) |
9-(6-Amino-3-pyridinyl)-1-[3-(trifluoromethyl)phenyl]benzo[h]-1,6-naphthyridin-2(1H)-one |
1223001-51-1 |
C24H15F3N4O |
 |
Torin 1 |
1222998-36-8 |
C35H28F3N5O2 |
 |
PHA-848125 |
802539-81-7 |
C25H32N8O |
 |
PURVALANOL A |
212844-53-6 |
C19H25ClN6O |
 |
Abemaciclib mesylate (LY2835219) |
1231930-82-7 |
C28H36F2N8O3S |
 |
PD0332991??????? |
827022-33-3 |
C26H35N7O6S |
 |
PHA767491???? |
845714-00-3 |
C12H11N3O |
![4-[(2,6-dichlorobenzoyl)amino]-N-4-piperidinyl1H-pyrazole-3-carboxamide](/CAS2/GIF/844442-38-2.gif) |
4-[(2,6-dichlorobenzoyl)amino]-N-4-piperidinyl1H-pyrazole-3-carboxamide |
844442-38-2 |
C16H17Cl2N5O2 |
 |
CH5132799 |
1007207-67-1 |
C15H19N7O3S |
 |
AVL-292 |
1202757-89-8 |
C22H22FN5O3 |
 |
PIK-294 |
900185-02-6 |
C28H23N7O2 |
 |
LY 2874455 |
1254473-64-7 |
C21H19Cl2N5O2 |
 |
WZ8040 |
1214265-57-2 |
C24H25ClN6OS |
![5-(3-Benzyloxyphenyl)-7-[trans-3-[(pyrrolidin-1-yl)methyl]cyclobutyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine](/CAS/GIF/475488-23-4.gif) |
5-(3-Benzyloxyphenyl)-7-[trans-3-[(pyrrolidin-1-yl)methyl]cyclobutyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
475488-23-4 |
C28H31N5O |
 |
PKI-402 |
1173204-81-3 |
C29H34N10O3 |
 |
BMS-265246 |
582315-72-8 |
C18H17F2N3O2 |
 |
ALK/IGF1R inhibitor |
1356962-20-3 |
C24H25ClN6O |
 |
Ribociclib |
1211441-98-3 |
C23H30N8O |
 |
ZM 306416 |
690206-97-4 |
C16H13ClFN3O2 |
![3-[(2,4-Dimethylpyrrol-5-yl)methylidenyl]-2-indolinon](/CAS/GIF/194413-58-6.gif) |
3-[(2,4-Dimethylpyrrol-5-yl)methylidenyl]-2-indolinon |
194413-58-6 |
C15H14N2O |
 |
A66 |
1166227-08-2 |
C17H23N5O2S2 |
 |
AMG-208 |
1002304-34-8 |
C22H17N5O2 |
 |
VS-5584 |
1246560-33-7 |
C17H22N8O |
 |
CP-724714 |
537705-08-1 |
C27H27N5O3 |
 |
NVP-BGT226 |
1245537-68-1 |
C28H25F3N6O2.C4H4O4 |
 |
BAY 80-6946 (Copanlisib) |
1032568-63-0 |
C23H28N8O4 |
 |
REVERSINE |
656820-32-5 |
C21H27N7O |
 |
TG003 |
300801-52-9 |
C13H15NO2S |
 |
AS 604850 |
648449-76-7 |
C11H5F2NO4S |
 |
AMG 458 |
913376-83-7 |
C30H29N5O5 |
![5-[[4-(4-Pyridinyl)-6-quinolinyl]methylene]-2,4-thiazolidenedione](/CAS/GIF/958852-01-2.gif) |
5-[[4-(4-Pyridinyl)-6-quinolinyl]methylene]-2,4-thiazolidenedione |
958852-01-2 |
C18H11N3O2S |
 |
GNF 5837 |
1033769-28-6 |
C28H21F4N5O2 |
 |
IGF-1R Inhibitor II, N-(5-Chloro-2-methoxyphenyl)-Nμ-(2-methylquinolin-4-yl)urea |
196868-63-0 |
C18H16ClN3O2 |
![2-[[(1R)-1-[7-methyl-2-(4-morpholinyl)-4-oxo-4h-pyrido[1,2-a]pyrimidin-9-yl]ethyl]amino]benzoic acid](/CAS2/GIF/1173900-33-8.gif) |
2-[[(1R)-1-[7-methyl-2-(4-morpholinyl)-4-oxo-4h-pyrido[1,2-a]pyrimidin-9-yl]ethyl]amino]benzoic acid |
1173900-33-8 |
C22H24N4O4 |
 |
NVP-BHG712 |
940310-85-0 |
C26H20F3N7O |
 |
Tepotinib |
1100598-32-0 |
C29H28N6O2 |
 |
GSK1838705A |
1116235-97-2 |
C27H29FN8O3 |
 |
TAK-285 |
871026-44-7 |
C26H25ClF3N5O3 |
 |
CZC24832 |
1159824-67-5 |
C15H17FN6O2S |
 |
XL765 |
1349796-36-6 |
C31H29N5O6S |
![3-(5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-pyrrolidine-2,5-dione](/CAS/GIF/905854-02-6.gif) |
3-(5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-pyrrolidine-2,5-dione |
905854-02-6 |
C23H19N3O2 |
 |
3,3'-(2,4-Diamino-6,7-pteridinediyl)bisphenol |
677297-51-7 |
C18H14N6O2 |
 |
PIK-75 Hydrochloride |
372196-77-5 |
C16H15BrClN5O4S |
 |
Capmatinib |
1029712-80-8 |
C23H17FN6O |
 |
BMS-754807 |
1001350-96-4 |
C23H24FN9O |
 |
FMOC-D-LYS(TEOC)-OH |
198545-00-5 |
C27H36N2O6Si |
 |
3-Phenyl-L-serine |
6254-48-4 |
C9H11NO3 |
 |
????(E7050) |
928037-13-2 |
C33H37F2N7O4 |
 |
BETA-(2-THIENYL)-DL-SERINE |
32595-59-8 |
C7H9NO3S |
 |
N-DICHLOROACETYL-L-SERINE SODIUM SALT |
80174-64-7 |
C5H7Cl2NO4 |
 |
2-(2-ETHYL-2,3-DIHYDRO-2-BENZOFURANYL)-1H-IMIDAZOLE |
189224-48-4 |
C13H14N2O |
 |
N-BOC-DL-SERINE |
69942-12-7 |
C9H17NO5 |
 |
Insulin-like Growth Factor-1 Receptor Inhibitor |
468740-43-4 |
C25H26ClN5O3 |
 |
OSI-420 |
183320-51-6 |
C21H22ClN3O4 |
 |
DL-N-BENZOYL-2-METHYLSERINE |
7508-82-9 |
C11H13NO4 |
 |
Z-GLY-GLY-SER-? |
98352-76-2 |
C15H19N3O7 |
 |
POLY-L-SERINE |
|
(C3H5NO2)n+H2O |
 |
AVP-AEW541 |
475489-16-8 |
C27H29N5O |
 |
L-Homoserine hydrochloride |
196950-52-4 |
C4H10ClNO3 |
 |
DL-N-BENZOYL-2-ISOPROPYLSERINE |
52421-46-2 |
C13H17NO4 |
 |
KRN 633 |
286370-15-8 |
C20H21ClN4O4 |
 |
R428 |
1037624-75-1 |
C30H34N8 |
 |
Sodium N-dodecanoyl-L-serinate |
70609-64-2 |
C15H28NNaO4 |
 |
(S)-3-(???????)-2-OXETANONE |
88109-06-2 |
C22H19NO2 |
 |
1,2-DIPALMITOYL-SN-GLYCERO-3-PHOSPHO-L-SERINE, SODIUM SALT |
40290-42-4 |
C38H74NO10P |
 |
N-BOC-ALPHA-METHYL-D-SERINE METHYL ESTER |
188476-33-7 |
C10H19NO5 |
 |
OSI-930 |
728033-96-3 |
C22H16F3N3O2S |
 |
NVP-BVU 972 |
1185763-69-2 |
C20H16N6 |
 |
N-???-5-METHOXY?? |
98632-99-6 |
C6H11NO4 |
 |
TYRPHOSTIN AG 1024 |
65678-07-1 |
C14H13BrN2O |
 |
N-Palmitoyl-L-serine |
16417-38-2 |
C19H37NO4 |
 |
DL-2-ISOPROPYLSERINE |
7522-43-2 |
C6H13NO3 |
 |
DL-2-BENZYLSERINE |
4740-47-0 |
C10H13NO3 |
 |
PD153035 HCl |
183322-45-4 |
C16H14BrN3O2.HCl |
 |
2-??-DL-?? ?????? |
3398-40-1 |
C4H9NO3 |
 |
ARRY-380 |
937265-83-3 |
C29H27N7O4S |
![N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine](/CAS/GIF/1097917-15-1.gif) |
N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine |
1097917-15-1 |
C29H40N8O3S |
 |
carbobenzoxyhomoserine |
41088-85-1 |
C12H15NO5 |
 |
N-(TRIPHENYLMETHYL)-DL-SERINE METHYL ESTER |
13515-76-9 |
C23H23NO3 |
![5-[3-Methoxy-4-(4-methoxy-benzyloxy)-benzyl]-pyrimidine-2,4-diamine](/CAS2/GIF/870483-87-7.gif) |
5-[3-Methoxy-4-(4-methoxy-benzyloxy)-benzyl]-pyrimidine-2,4-diamine |
870483-87-7 |
C20H22N4O3 |
![1-{2-[5-(2-Methoxy-ethoxy)-benzoimidazol-1-yl]-quinolin-8-yl}-piperidin-4-ylamine](/CAS2/GIF/343787-29-1.gif) |
1-{2-[5-(2-Methoxy-ethoxy)-benzoimidazol-1-yl]-quinolin-8-yl}-piperidin-4-ylamine |
343787-29-1 |
C24H27N5O2 |
 |
(S)-N-BOC-2-AMINO-3-ETHOXY-PROPIONIC ACID |
104839-00-1 |
C10H19NO5 |
 |
Icotinib |
610798-31-7 |
C22H21N3O4 |
 |
Sodium N-palmitoyl-L-serinate |
58725-46-5 |
C19H36NNaO4 |
 |
N-Myristoyl-L-serine |
21394-57-0 |
C17H33NO4 |
 |
FMOC-SER(AC)-OH |
171778-17-9 |
C20H19NO6 |
 |
N-ME-SER(TBU)-OH |
197632-83-0 |
C8H17NO3 |
 |
N-BENZYL-L-SERINE, METHYL ESTER |
123639-56-5 |
C11H15NO3 |
 |
Boc-D-Homoserine |
67198-87-2 |
C9H18NNaO5 |
 |
(2R,3S)-3-phenylisoserine methyl ester |
131968-74-6 |
C10H13NO3 |